Xiaoyi Mi

979 total citations
42 papers, 768 citations indexed

About

Xiaoyi Mi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaoyi Mi has authored 42 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 20 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Xiaoyi Mi's work include NF-κB Signaling Pathways (9 papers), Epigenetics and DNA Methylation (7 papers) and interferon and immune responses (6 papers). Xiaoyi Mi is often cited by papers focused on NF-κB Signaling Pathways (9 papers), Epigenetics and DNA Methylation (7 papers) and interferon and immune responses (6 papers). Xiaoyi Mi collaborates with scholars based in China, United States and Sweden. Xiaoyi Mi's co-authors include Enhua Wang, Minjie Wei, Lin Zhao, Zhaojin Yu, Xuefeng Bai, Min Song, Weifan Yao, Fan Yang, Feng Jin and Jie Ren and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Xiaoyi Mi

41 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyi Mi China 17 596 254 244 75 55 42 768
Maozhen Tian United States 8 540 0.9× 179 0.7× 364 1.5× 76 1.0× 60 1.1× 8 760
Min-Wei Chen Taiwan 13 788 1.3× 257 1.0× 195 0.8× 97 1.3× 40 0.7× 14 977
Chaoju Gong China 14 364 0.6× 216 0.9× 211 0.9× 67 0.9× 73 1.3× 28 619
Christy L. Trejo United States 10 444 0.7× 206 0.8× 416 1.7× 68 0.9× 51 0.9× 12 670
Antonio Díaz‐López Spain 13 375 0.6× 302 1.2× 272 1.1× 50 0.7× 85 1.5× 15 682
Sylvia Mahara Singapore 8 502 0.8× 179 0.7× 210 0.9× 80 1.1× 42 0.8× 9 658
Tiziana Tonini United States 11 431 0.7× 143 0.6× 229 0.9× 58 0.8× 60 1.1× 15 646
Hanshao Liu Japan 9 617 1.0× 380 1.5× 190 0.8× 44 0.6× 34 0.6× 13 777
E. Ken Parkinson United Kingdom 8 421 0.7× 196 0.8× 251 1.0× 87 1.2× 30 0.5× 8 744
Wai Kei Kwok Hong Kong 6 504 0.8× 230 0.9× 279 1.1× 50 0.7× 42 0.8× 6 702

Countries citing papers authored by Xiaoyi Mi

Since Specialization
Citations

This map shows the geographic impact of Xiaoyi Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyi Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyi Mi more than expected).

Fields of papers citing papers by Xiaoyi Mi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyi Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyi Mi. The network helps show where Xiaoyi Mi may publish in the future.

Co-authorship network of co-authors of Xiaoyi Mi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyi Mi. A scholar is included among the top collaborators of Xiaoyi Mi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyi Mi. Xiaoyi Mi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiao, Yuan-li Ai, Xiaoyi Mi, et al.. (2025). cGAS activation converges with intracellular acidification to promote STING aggregation and pyroptosis in tumor models. Journal of Clinical Investigation. 135(18). 3 indexed citations
2.
Zhao, Gexin, et al.. (2022). Ajuba Overexpression Promotes Breast Cancer Chemoresistance and Glucose Uptake through TAZ‐GLUT3/Survivin Pathway. BioMed Research International. 2022(1). 3321409–3321409. 9 indexed citations
3.
He, Bin, Lei Wu, Xiaoyi Mi, et al.. (2022). Exposure to particulate matter 2.5 leading to lung microbiome disorder and the alleviation effect of <i>Auricularia auricular-judae</i> polysaccharide. International Journal of Occupational Medicine and Environmental Health. 35(6). 651–664. 4 indexed citations
4.
Xu, Lu, Jing Shi, Lei Zhao, et al.. (2020). Prognostic Value and Influence of Receptor Conversion on Treatment Regimen in Metastatic Breast Cancer at the First Time of Recurrence. Oncology Research and Treatment. 43(11). 620–627. 6 indexed citations
5.
Liu, Yang, Juan‐Han Yu, Jie Zhang, et al.. (2020). Mixed granulosa-Sertoli sex cord-stromal tumor of the testis: clinical, ultrasonic and histopathological features: a case report. Translational Andrology and Urology. 9(6). 2836–2841. 1 indexed citations
6.
Mi, Xiaoyi, Xueyan Zhao, Na Wei, et al.. (2020). TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin. Breast Cancer Research and Treatment. 183(2). 275–289. 13 indexed citations
7.
Zhang, Jie, et al.. (2019). FAM53A Affects Breast Cancer Cell Proliferation, Migration, and Invasion in a p53-Dependent Manner. Frontiers in Oncology. 9. 1244–1244. 10 indexed citations
8.
Yang, Fan, Jian Wang, Juan Jin, et al.. (2015). Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression. Tumor Biology. 36(8). 5901–5911. 30 indexed citations
9.
Wang, Jian, Lili Sun, Juan Jin, et al.. (2015). Expression of tumor necrosis factor receptor-assicated factor 4 correlates with expression of Girdin and promotes nuclear translocation of Girdin in breast cancer. Molecular Medicine Reports. 11(5). 3635–3641. 9 indexed citations
10.
Xiao, Qinghuan, Xuefeng Bai, Zhaojin Yu, et al.. (2014). Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer. Oncology Reports. 32(6). 2760–2768. 51 indexed citations
11.
Sun, Lili, Jian Wang, Ning Liu, et al.. (2014). Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2. Oncology Reports. 31(5). 2085–2092. 36 indexed citations
13.
14.
15.
Li, Yanlin, Lin Zhao, Jiankun Yu, et al.. (2012). Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells. PLoS ONE. 7(8). e44254–e44254. 21 indexed citations
16.
Han, Yang, Yong Zhang, Lian‐He Yang, et al.. (2012). X-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer. Radiation Oncology. 7(1). 183–183. 16 indexed citations
17.
Zhao, Lin, Zhaojin Yu, Yunan Li, et al.. (2011). Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women. Medical Oncology. 29(3). 1569–1575. 6 indexed citations
18.
Cui, Wei, Lihui Wang, Yuanyuan Wen, et al.. (2010). Expression and regulation mechanisms of Sonic Hedgehog in breast cancer. Cancer Science. 101(4). 927–933. 76 indexed citations
19.
Liu, Jinyi, Dongyun Zhang, Xiaoyi Mi, et al.. (2010). p27 Suppresses Arsenite-induced Hsp27/Hsp70 Expression through Inhibiting JNK2/c-Jun- and HSF-1-dependent Pathways. Journal of Biological Chemistry. 285(34). 26058–26065. 31 indexed citations
20.
Qiu, Lihong, et al.. (2008). PI3K/Akt mediates expression of TNF‐α mRNA and activation of NF‐κB in calyculin A‐treated primary osteoblasts. Oral Diseases. 14(8). 727–733. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026